Conditions: Atopic Dermatitis
Keywords: Atopic dermatitis, children, infants, pimecrolimus
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 2418
Healthy volunteers: no

Brief summary:
The primary purpose of this study is to investigate the safety of pimecrolimus cream 1% in the long-term treatment (up to 5 years) of atopic dermatitis (eczema) in patients less than 12 months of age compared to topical corticosteroids (TCS).

Detailed description:

Arms:
arm 1: Pimecrolimus arm 2: Topical corticosteroids

Interventions: intervention 1: Pimecrolimus intervention 2: Topical corticosteroids
Intervention descriptions: intervention 1: Pimecrolimus cream 1 % intervention 2: TCS

Protocol document: